Szilvia Torok

Summary

Country: Hungary

Publications

  1. ncbi [Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects]
    Szilvia Torok
    Tumorbiológiai Osztály, Országos Korányi Tbc és Pulmonológiai Intézet, Budapest, Hungary
    Magy Onkol 56:199-208. 2012
  2. doi [Possibilities for inhibiting tumor-induced angiogenesis: results with multi-target tyrosine kinase inhibitors]
    Szilvia Torok
    Országos Korányi Tbc és Pulmonológiai Intézet, Tumorbiológiai Osztály, Budapest, Hungary
    Magy Onkol 56:3-15. 2012
  3. pmc Apelin promotes lymphangiogenesis and lymph node metastasis
    Judit Berta
    Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria Department of Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary
    Oncotarget 5:4426-37. 2014
  4. doi Lung cancer in never smokers
    Szilvia Torok
    National Koranyi Institute of Pulmonology, Budapest, Hungary
    Future Oncol 7:1195-211. 2011

Collaborators

Detail Information

Publications4

  1. ncbi [Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects]
    Szilvia Torok
    Tumorbiológiai Osztály, Országos Korányi Tbc és Pulmonológiai Intézet, Budapest, Hungary
    Magy Onkol 56:199-208. 2012
    ..Nintedanib might also be combined with paclitaxel, carboplatin, pemetrexed and docetaxel. There are several ongoing clinical trials testing the efficacy of BIBF 1120...
  2. doi [Possibilities for inhibiting tumor-induced angiogenesis: results with multi-target tyrosine kinase inhibitors]
    Szilvia Torok
    Országos Korányi Tbc és Pulmonológiai Intézet, Tumorbiológiai Osztály, Budapest, Hungary
    Magy Onkol 56:3-15. 2012
    ..On the other hand, the optimal combination and dosage of these drugs, selection of the apropriate biomarker and better understanding of the conflicting role of PDGFR and FGFR signaling in angiogenesis remain future challenges...
  3. pmc Apelin promotes lymphangiogenesis and lymph node metastasis
    Judit Berta
    Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria Department of Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary
    Oncotarget 5:4426-37. 2014
    ..Our study does not only reveal apelin as a novel lymphangiogenic factor but might also open the door for the development of novel anticancer therapies targeting lymphangiogenesis. ..
  4. doi Lung cancer in never smokers
    Szilvia Torok
    National Koranyi Institute of Pulmonology, Budapest, Hungary
    Future Oncol 7:1195-211. 2011
    ..Future studies on LCINS should try to tackle the issues of prevention, early diagnosis and the exploration of novel therapeutic targets to combat lung cancer disease...